Prevalence of GAD(65) and IA-2 autoantibodies in IDDM patients with nephropathy.

被引：0
作者：
Zerbini, G [1 ]
Bazzigaluppi, E [1 ]
Mangili, R [1 ]
Bosi, E [1 ]
Bonifacio, E [1 ]
机构：
[1] IST SCI SAN RAFFAELE,MILAN,ITALY
来源：
DIABETOLOGIA | 1997年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2090 / 2090
页数：1
相关论文
共 50 条
  • [21] IA-2-autoantibodies complement GAD(65)-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings
    Gorus, FK
    Goubert, P
    Semakula, C
    Vandewalle, CL
    DeSchepper, J
    Scheen, A
    Christie, MR
    Pipeleers, DG
    Balasse, E
    Becq, H
    Beirinckx, J
    Claeys, L
    Coeckelberghs, M
    Coolens, JL
    Coucke, W
    Couturier, E
    Craen, R
    Daubresse, JC
    DeLeeuw, I
    Defoer, F
    Delvigne, C
    Dorchy, H
    DuCaju, M
    Fery, F
    Gaham, M
    Gerard, J
    Gillet, C
    Guiot, J
    Herbaut, C
    Keymeulen, B
    Krzentowski, G
    Lamberigts, G
    Lauvaux, JP
    Letiexhe, M
    Monballyu, J
    Moorkens, G
    Nicolaij, D
    Nobels, F
    Pelckmans, MC
    Purnode, A
    Rooman, R
    Rottiers, R
    Schutyser, J
    Somers, G
    Terriere, L
    Teuwen, J
    Tits, J
    VanAcker, K
    VanCrombrugge, P
    VAnGaal, L
    DIABETOLOGIA, 1997, 40 (01) : 95 - 99
  • [22] Diagnostic sensitivity of autoantibodies to tyrosine phosphatase-like proteins IA-2 and IA-2 beta in IDDM and NIDDM
    Seissler, J
    Morgenthaler, NG
    Steinbrenner, H
    KhooMorgenthaler, UY
    Lan, MS
    Notkins, AL
    Scherbaum, WA
    DIABETOLOGIA, 1997, 40 : 284 - 284
  • [23] Reference limits for GAD65 and IA-2 autoantibodies by chemiluminescence immunoassay in Northern European adults and children
    Ziobrowska-Bech, Agnes
    Winther-Larsen, Anne
    Kremke, Britta
    Parkner, Tina
    Knudsen, Cindy Soendersoe
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2019, 79 (1-2) : 123 - 125
  • [24] GAD65 autoantibodies in IDDM patients have preference for different GAD65 species
    Hampe, C
    Lernmark, Å
    Persson, B
    Örtquist, E
    Rolandsson, O
    Hallmans, G
    Östman, J
    DIABETES, 1998, 47 : A204 - A204
  • [25] The prevalence of early somatic neuropathy in children and adolescents with type 1 diabetes and its association with the persistence of GAD-65 and IA-2 autoantibodies
    Karachaliou, F.
    Louraki, M.
    Katsalouli, M.
    Kanaka-Gantenbein, C.
    Critselis, E.
    Kafasi, N.
    Kallinikou, D.
    Tsentidis, C.
    Karavanaki, K.
    DIABETOLOGIA, 2015, 58 : S496 - S496
  • [26] IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings
    F. K. Gorus
    P. Goubert
    C. Semakula
    C. L. Vandewalle
    J. De Schepper
    A. Scheen
    M. R. Christie
    D. G. Pipeleers
    Diabetologia, 1997, 40 : 95 - 99
  • [27] Prevalence and levels of GAD and IA-2 autoantibodies in patients with long duration of type 1 diabetes at the time of screening for islet transplantation
    Monroy, Kathy
    Faradji, Raquel N.
    Allende, Gloria
    Gorn, Lisa
    Denham, Misha
    Kury Perez, Elizabeth M.
    Messinger, Shari
    Cure, Pablo
    Baidal, David A.
    Froud, Tatiana
    Ponte, Gaston
    Ricordi, Camillo
    Pugliese, Alberto
    Alejandro, Rodolto
    DIABETES, 2007, 56 : A271 - A271
  • [28] Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM
    Yokota, I
    Matsuda, J
    Naito, E
    Ito, M
    Shima, K
    Kuroda, Y
    DIABETES CARE, 1998, 21 (01) : 49 - 52
  • [29] Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM
    Genovese, S
    Bonfanti, R
    Bazzigaluppi, E
    Lampasona, V
    Benazzi, E
    Bosi, E
    Chiumello, G
    Bonifacio, E
    DIABETOLOGIA, 1996, 39 (10) : 1223 - 1226
  • [30] Associations of GAD65- and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings
    Vandewalle, CL
    Falorni, A
    Lernmark, A
    Goubert, P
    Dorchy, H
    Coucke, W
    Semakula, C
    VanderAuwera, B
    Kaufman, L
    Schuit, FC
    Pipeleers, DG
    Gorus, FK
    Balasse, E
    Becq, H
    Bodson, A
    Claeys, L
    Coeckelberghs, M
    Coolens, JL
    Couturier, E
    Craen, R
    Daubresse, JC
    Decraene, P
    DeLeeuw, I
    Delvigne, C
    DeSchepper, J
    DuCaju, M
    Fery, F
    Gaham, N
    Gerard, J
    Gillet, C
    Guiot, J
    Herbaut, C
    Keymeulen, B
    Krzentowski, G
    Lamberigts, G
    Letiexhe, M
    Logghe, K
    Monballyu, J
    Nicolaij, D
    Nobels, F
    Pelckmans, MC
    Purnode, A
    Roggemans, MP
    Rottiers, R
    Scheen, A
    Schutyser, J
    Terriere, L
    Teuwen, J
    Thenaers, G
    VanAcker, K
    DIABETES CARE, 1997, 20 (10) : 1547 - 1552
12345